Recent findings from an NIH-supported trial indicate that intravenous acetaminophen may help reduce organ injury and acute respiratory distress syndrome in sepsis patients, particularly those at severe risk. The study suggests potential benefits in using acetaminophen for critically ill patients, though further research is required.
Results from an NIH-supported clinical trial indicate that the drug is most effective in the most severely ill patients.
A clinical trial supported by the DOI: 10.1001/jama.2024.8772
This study was supported by NHLBI grants: U01 HL122989, U01 HL122998, U01 HL123004, U01 HL123008, U01 HL123009, U01 HL123010, U01 HL123018, U01 HL123020, U01 HL123022, U01 HL123023, U01 HL123027, U01 HL123031, and U01 HL123033.